The U.S. Food and Drug Administration has approved Jobevne (bevacizumab-nwgd), a biosimilar to Avastin (bevacizumab) for ...

Ovarian cancer is one of those. Ovarian cancer starts in the ovaries, which are two small glands located on either side of the uterus that produce eggs and important hormones like estrogen and ...

Drs Ursula A. Matulonis and Gini F. Fleming discuss the state of endometrial cancer, the role of immunotherapy, and priorities for research in this field.

Biocon Biologics, a subsidiary of India-based Biocon Ltd, said on Thursday that U.S. FDA has approved Jobevne, a biosimilar ...

Four leading companies CTMC, Iovance Therapeutics, KSQ, and TILT Biotherapeutics prognosticate coming successes of new technology approaches to better tumor-infiltrating lymphocyte activities.

Last week, President Donald Trump signed an executive order imposing a minimum 10% tariff on all U.S. imports, with certain ...

Research has shed light on how a new type of antibody treatment reactivates patients' immune cells to fight ovarian cancer.

In a special article published online March 19 in the Journal of Clinical Oncology, the American Society of Clinical Oncology ...

The FDA has approved bevacizumab-nwgd, a biosimilar to bevacizumab, for intravenous use across multiple cancer types.

To say the last few years of Olivia Munn’s life have been a rollercoaster doesn’t fully capture what she’s been through.

BRIDGEWATER, N.J. and BENGALURU, India, April 10, 2025 /PRNewswire/ -- Biocon Biologics Ltd (BBL), a subsidiary of Biocon Ltd (BSE code: 532523, NSE: BIOCON), today announced that the ...